Defiance KSM Israel 120 ETF financials
$24.21−1.60%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | -$126.6K | -$245.3K | -$252.9K | -$281.0K | -$349.1K | -$281.3K | -$250.2K | -$234.3K | -$293.7K | -$631.8K | -$314.9K | -$185.7K |
| Net income | -$65.1K | -$32.8K | -$40.4K | -$43.8K | -$238.1K | -$30.2K | -$23.8K | -$22.9K | $930.6K | $866.0K | $10.1M | -$6.7K |
| Net margin | — | — | — | — | — | — | — | — | — | — | — | — |
| Diluted EPS | $-0.02 | $-0.04 | — | $-0.06 | $-0.07 | $-0.04 | $0.28 | $-0.03 | $0.13 | $0.12 | $0.36 | $-0.01 |
| EBITDA | -$45.5K | -$70.5K | -$109.7K | -$138.4K | -$162.2K | -$124.1K | -$124.0K | -$142.8K | -$141.8K | -$253.2K | -$643.5K | -$101.2K |
| Operating cash flow | -$19.7K | -$82.0K | $37.6K | -$103.0K | -$58.6K | -$134.3K | $864.7K | $855.0K | $779.7K | $848.6K | $302.0K | -$32.6K |
| Free cash flow | -$19.7K | -$82.0K | $37.6K | -$103.0K | -$58.6K | -$134.3K | $864.7K | $855.0K | $779.7K | $848.6K | $302.0K | -$32.6K |
| Diluted shares | 3.5M | 0.8M | — | 0.8M | 3.2M | 0.8M | 13.8M | 0.8M | 7.3M | 7.9M | 28.0M | 0.8M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.7K | $32.6K | $6.9K | $63.8K | $57.3K | $27.2K |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $2.2M | $2.1M | $1.9M | $1.8M | $1.6M | $6.7M |
| Total assets | $6.4M | $6.4M | $10.0M | $9.9M | $9.7M | $9.5M |
| Total liabilities | $8.4M | $8.3M | $8.0M | $8.0M | $7.6M | $7.2M |
| Shareholders' equity | -$8.4M | -$8.2M | -$8.0M | -$7.9M | -$7.5M | -$7.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology